Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 24463189)

1.

Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.

Rahbari-Oskoui F, Williams O, Chapman A.

Nephrol Dial Transplant. 2014 Dec;29(12):2194-201. doi: 10.1093/ndt/gft513. Epub 2014 Jan 23. Review.

PMID:
24463189
2.

Hypertension in autosomal dominant polycystic kidney disease.

Chapman AB, Stepniakowski K, Rahbari-Oskoui F.

Adv Chronic Kidney Dis. 2010 Mar;17(2):153-63. doi: 10.1053/j.ackd.2010.01.001. Review.

3.
4.

Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.

Tkachenko O, Helal I, Shchekochikhin D, Schrier RW.

Curr Hypertens Rev. 2013 Feb;9(1):12-20. Review.

PMID:
23971639
5.

The pathogenesis of hypertension in autosomal dominant polycystic kidney disease.

Wang D, Strandgaard S.

J Hypertens. 1997 Sep;15(9):925-33. Review.

PMID:
9321739
6.

Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.

Masoumi A, Elhassan E, Schrier RW.

Iran J Kidney Dis. 2011 Jan;5(1):1-8. Review.

7.

Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Ecder T, Schrier RW.

Nat Rev Nephrol. 2009 Apr;5(4):221-8. doi: 10.1038/nrneph.2009.13. Review.

8.
9.

Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.

Chapman AB.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1197-204. doi: 10.2215/CJN.00060108. Epub 2008 Jun 25. Review.

10.

Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.

Lawson CR, Doulton TW, MacGregor GA.

J Renin Angiotensin Aldosterone Syst. 2006 Sep;7(3):139-45. Review.

PMID:
17094050
11.

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.

Chapman AB, Johnson A, Gabow PA, Schrier RW.

N Engl J Med. 1990 Oct 18;323(16):1091-6.

12.

Optimal care of autosomal dominant polycystic kidney disease patients.

Schrier RW.

Nephrology (Carlton). 2006 Apr;11(2):124-30. Review.

PMID:
16669974
13.

Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.

Chapman AB, Schrier RW.

Semin Nephrol. 1991 Nov;11(6):653-60. Review.

PMID:
1767138
14.
15.

Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).

Cadnapaphornchai MA.

Curr Hypertens Rev. 2013 Feb;9(1):21-6. Review.

PMID:
23971640
16.

Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.

Cerasola G, Li Vecchi M, Mulé G, Cottone S, Mangano MT, Andronico G, Contomo A, Parrino IA, Renda F, Pavone G, Scialabba A.

Contrib Nephrol. 1997;122:22-7. No abstract available.

PMID:
9399032
17.

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.

Loghman-Adham M, Soto CE, Inagami T, Cassis L.

Am J Physiol Renal Physiol. 2004 Oct;287(4):F775-88. Epub 2004 Jun 8.

18.

Hypertension in autosomal dominant polycystic kidney disease.

Chapman AB, Gabow PA.

Kidney Int Suppl. 1997 Oct;61:S71-3. Review. No abstract available.

PMID:
9328971
19.

Cardiovascular complications in autosomal dominant polycystic kidney disease.

Ecder T.

Curr Hypertens Rev. 2013 Feb;9(1):2-11. Review.

PMID:
23971638
20.

A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.

Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, Orscelik O, Sipahioglu MH, Tokgoz B, Oymak O.

Am J Nephrol. 2013;38(3):218-25. doi: 10.1159/000354317. Epub 2013 Aug 28.

PMID:
23988725
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk